Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
Fig 3
Evolution of the age- and sex-standardised and crude prevalence rates of polypharmacy (≥5 drugs) from 2000–2015.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Evolution of the age- and sex-standardised and crude prevalence rates of polypharmacy (≥5 drugs) from 2000–2015.